<DOC>
	<DOCNO>NCT02427607</DOCNO>
	<brief_summary>To evaluate safety tolerability perampanel give adjunctive therapy participant epilepsy . This study continue perampanel commercially available .</brief_summary>
	<brief_title>Open-label Extension Study Evaluate Safety Tolerability Perampanel ( E2007 ) Administered Adjunctive Therapy Epilepsy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Inclusion Criteria 1 . Participants participate designate perampanel study , opinion investigator continue benefit treatment perampanel Designated perampanel study : E2007G000332 ( NCT01393743 ) ( least 52 week total exposure perampanel ) . 2 . Provide write informed consent/assent sign participant legal guardian prior enter study undergo study procedure . If write informed consent provide legal guardian participant unable , write verbal assent participant must also obtain . 3 . Female participant childbearing potential must agree duration study period least 1 month follow last dose perampanel abstinent commit consistent correct use medically acceptable method birth control ( eg , doublebarrier method [ condom plus spermicide , condom plus diaphragm spermicide ] ) . Exclusion Criteria 1 . Participants reside country perampanel commercially available respect indication formulation designate perampanel study . 2 . Female participant nursing , pregnant , plan become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Perampanel</keyword>
</DOC>